real-epidermal junction in mechanobullous diseases. J Invest Dermatol 76:113-1 I8, 1981. 19. Bauer EA, Cooper TW, Tucker DR, Esterly NB: Phenyltoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase. N Eng/ J Med 303:776-781, 1980. 20. Carter DM: Human diseases characterized by heritable DNA instability. Birth Defects 17:117-128, 1981. 21. Friedberg EC, Ehmann UK, Williams Jl: Human diseases associated with defective DNA repair. Adv Rad Biol 8:85-174, 1979. 22. Schroeder TM: Genetically determined chromosome instability syndromes. Cytogenet Cell Genet 33: l 19-132, 1982. 23. Jaspers NG, Bootsma D: Genetic heterogeneity in ataxia telangiectasia studied by cell fusion. Proc Natl Acad Sci USA 79:2641-2644, 1982. 24. Murnane JP, Painter RB: Complementation of the defects of DNA synthesis in irradiated and unirradiated ataxia telangiectasia cells. Proc Natl Acad Sci USA 79:19601963, 1982. 25. Shaham M, Voss P,, Becker Y, et al: Prenatal diagnosis of ataxia telangiectasia. J Pediatr 100:134-137, 1982. 26. Alter BP, Potter NU: Long-term outcome in Fanconi's anemia: description of 26 cases and review of the literaturc, in German J, editor: Chromosome breakage and neoplasia. New York, 1983, Alan R. Liss, Inc.. pp. 4362. 27. Auerbach AD, Adler B, Chaganti RSK: Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method. Pediatrics 67:128-135, 1981. 28. Carter DM, Pan M, Gaynor A, et al: Psoralen-DNA cross-linking photoadducts in dyskcratosis congenita: Delay in excision and promotion of sister ehromatid exchange. J Invest Dermatol 73:97-101, 1979. 29. German J, Bloom D, Passarge E: Bloom's syndrome. VII. Progress report for 1978. Clin Genet 15:361-367, 1979. 30. Giannelli F, Pawsey SA, Avery JA: Differences in patterns of complementation of the more common groups of xeroderma pigmentosum: Possible implications. Cell 29:451-458, I982. 31. Halley DJJ, Keijzer W, Jaspers NGJ, et al: Prenatal diagnosis of xeroderma pigmentosum (group C) using assays of unscheduled DNA synthesis and postreplication repair. Clin Genet 16: t37-146, 1979. 32. Keijzer W, Verkerk A, Bootsma D: Phcnotypic correction of the defect in xeroderma pigmentosum cells after fusion with isolated cytoplasts. Exp Cell Res 140:119-125, I982. 33. Kraning KK, Odland GF, editors: Analysis of research needs and priorities in dermatology. Chapter VI. Birth defects and genetic disorders. J Invest Dermatol 73:460472, 1979. 34. Rhodes AR, Melski JW: Small congenital nevocellular nevi and the risk of cutaneous melanoma. J Pediatr 100:219-224, 1982. 35. Howanitz N, Nordlund J J, Lerner AB, Bystryn JC: Antibodies to melanocytes in patients with vitiligo. Arch DermatoI 117:705-708, 1981. 36. Nordlund J J, Lemer AB: Vitiligo: It is important. Arch Dermatol 118:5-9, 1982. 37. Nordlund JJ, Howanitz N, Bystryn JC, et al: Anti-pigment cell factors and mucocutaneous candidiasis. Arch Dermatol 117:210-212, 1981.
Read full abstract